EFNB2, in line with ITGA5, was highly expressed in cancer tissues, compared with normal tissues (Figure 5S-T), and high expression of EFNB2 conferred a poor prognosis in LSCC patients (Figure 5U). The gene discussed is ITGA5; the disease is cancer.